Saltoro Capital’s Encompass Health EHC Stock Holding History

Saltoro Capital’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,514	Closed	-$156K	–	109
2021 Q2	$156K	Sell	2,514 -4,274	-63%	-$285K	0.06%	83
2021 Q1	$442K	Buy	+6,788	New	+$443K	0.11%	77

Other funds holding EHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Saltoro Capital's EHC Position: Q3 2021 in Review

Saltoro Capital sold out of Encompass Health (EHC) in Q3 2021, closing a stake of 2,514 shares — an estimated $156K sold.

Saltoro Capital first reported a position in EHC in Q1 2021 and held it in 2 quarters. The position peaked at $442K in Q1 2021. 436 funds tracked by Wall St. Rank hold EHC as of Q3 2021.

Saltoro Capital reported no remaining Encompass Health position as of Q3 2021 after selling out during the quarter.
Saltoro Capital sold 2,514 Encompass Health shares in Q3 2021, an estimated $156K.
Saltoro Capital first reported a position in Encompass Health in Q1 2021 and held it in 2 quarters.
Saltoro Capital's Encompass Health position peaked at $442K in Q1 2021.
436 funds tracked by Wall St. Rank held Encompass Health as of Q3 2021.

Based on Saltoro Capital's 13F filing for Q3 2021, filed 12 Nov 2021.